Accessibility Menu
DarioHealth logo

DarioHealth

(NASDAQ) DRIO

Current Price$7.61
Market Cap$60.35M
Since IPO (2013)-100%
5 Year-98%
1 Year-43%
1 Month-29%

DarioHealth Financials at a Glance

Market Cap

$60.35M

Revenue (TTM)

$24.73M

Net Income (TTM)

$33.93M

EPS (TTM)

$-18.03

P/E Ratio

-0.50

Dividend

$0.00

Beta (Volatility)

1.17 (Average)

Price

$7.61

Volume

18,890

Open

$9.37

Previous Close

$8.24

Daily Range

$7.61 - $9.37

52-Week Range

$5.93 - $17.74

DRIO News

No articles available.

DRIO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About DarioHealth

Industry

Health Care Technology

Employees

202

CEO

Erez Raphael

Headquarters

New York City, NY 10011, US

DRIO Financials

Key Financial Metrics (TTM)

Gross Margin

64%

Operating Margin

84%

Net Income Margin

-1%

Return on Equity

-43%

Return on Capital

19%

Return on Assets

-29%

Earnings Yield

-2.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$60.35M

Shares Outstanding

6.76M

Volume

18.89K

Short Interest

0.00%

Avg. Volume

17.28K

Financials (TTM)

Gross Profit

$13.27M

Operating Income

$57.74M

EBITDA

$50.32M

Operating Cash Flow

$38.56M

Capital Expenditure

$138.00K

Free Cash Flow

$38.70M

Cash & ST Invst.

$28.46M

Total Debt

$30.19M

DarioHealth Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$5.01M

-32.5%

Gross Profit

$3.02M

-42.3%

Gross Margin

60.22%

N/A

Market Cap

$60.35M

N/A

Market Cap/Employee

$307.92K

N/A

Employees

196

N/A

Net Income

$2.08M

+83.2%

EBITDA

$8.73M

+15.4%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$491.00K

+103.3%

Accounts Receivable

$2.38M

-71.6%

Inventory

$4.87M

+2.7%

Long Term Debt

$31.20M

+47.0%

Short Term Debt

$442.00K

-95.2%

Return on Assets

-28.82%

N/A

Return on Invested Capital

19.17%

N/A

Free Cash Flow

$7.39M

-0.0%

Operating Cash Flow

$7.35M

+0.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VSTMVerastem, Inc.
$5.82+4.68%
PACBPacific Biosciences of California, Inc.
$1.40+5.26%
RGNXREGENXBIO Inc.
$8.36+0.97%
MYGNMyriad Genetics, Inc.
$4.75+2.37%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$45.69-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.35+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.97-0.06%
QQQInvesco QQQ Trust
$593.02-0.00%

Questions About DRIO

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.